<?xml version='1.0' encoding='utf-8'?>
<document id="25705907"><sentence text="Quantitative evaluation of drug-drug interaction potentials by in vivo information- guided prediction approach." /><sentence text="Drug-drug interaction (DDI) is one important topic in drug discovery, drug development and clinical practice" /><sentence text=" Recently, a novel approach, in vivo information-guided prediction (IVIP), was introduced for predicting the magnitude of pharmacokinetic DDIs which are caused by changes in cytochrome P450 (CYP) activity" /><sentence text=" This approach utilizes two parameters, i" /><sentence text="e" /><sentence text=" CR (the apparent contribution of the target metabolizing enzyme to the clearance of the substrate drug) and IX (the apparent effect of a perpetrator on the target CYP) to describe the magnitude of DDI between a perpetrator and a victim drug" /><sentence text=" The essential concept of this method assumes that at a given dose level, the IX for a given perpetrator remains constant whatever the victim drug is" /><sentence text=" Usually, this IVIP method is only based on information from clinical studies and does not need in vitro information" /><sentence text=" In this review, basic concept, application and extension, as well as pros and cons of the IVIP method were presented" /><sentence text=" How to apply this approach was also discussed" /><sentence text=" Thus far, this method displayed good performance in predicting DDIs associated with CYPs, and can be used to forecast the magnitude of a large number of possible DDIs, of which only a small portion have been investigated in clinical studies" /><sentence text=" The key concept of this static approach could even be implemented in dynamic modeling to assess risks of DDIs involving drug transporters" /><sentence text=" " /></document>